Triple-negative breast cancer (TNBC) is characterized by a subtype of invasive breast cancer that does not express three important molecular markers including estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2) [2]. Here, ERBB2 is linked to triple-negative breast carcinoma.